Individually Adapted Therapy of Alcoholism: Clinical Studies

NCT00317031 Phase 4 COMPLETED

The primary objective is to directly compare the efficacy of acamprosate, naltrexone and placebo for relapse prevention in alcoholics.

Details

Lead sponsor	Central Institute of Mental Health, Mannheim
Phase	Phase 4
Status	COMPLETED
Enrolment	435
Start date	2002-11
Completion	2008-06

Conditions

• Alcoholism

Interventions

• Acamprosate or Naltrexone

Primary outcomes

• time to relapse to heavy drinking (consumption of more than 48 gram alcohol/day for females and more than 60 gram alcohol/day for males) — 06/2008

Countries

Germany